Surgical Neurology
Volume 65, Issue 1 , Pages 7-10 , January 2006

Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury

  • Taner Tanriverdi, MD

      Affiliations

    • Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Mustafa Uzan, MD

      Affiliations

    • Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. PO Box 5, Cerrahpasa, 34301 Istanbul, Turkey. Tel.: +90 212 414 34 27; fax: +90 212 414 34 27.
    • ,
  • Galip Zihni Sanus, MD

      Affiliations

    • Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Onur Baykara, MSc

      Affiliations

    • Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Merih Is, MD

      Affiliations

    • Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Cigdem Ozkara, MD

      Affiliations

    • Department of Neurosurgery, Medical Faculty, Duzce Izzet Baysal University, Duzce, Turkey
    • ,
  • Nur Buyra, PhD

      Affiliations

    • Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey

Received 1 November 2004 ,Accepted 16 May 2005.

References 

  1. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734–744
  2. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1α and IL-1β in ischemic brain damage. J Neurosci. 2001;21:5528–5534
  3. Bullock R, Chesnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, et al. Guidelines of the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med. 1996;13:109–127
  4. Green EK, Harris JM, Lemmon H, Lambert JC, Chartier-Harlin MC, St Clair D, et al. Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?. Neurology. 2002;58:1566–1568
  5. Griffin WST, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW. Neurosci Lett. 1994;176:133–136
  6. Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, et al. Association of early-onset Alzheimer's disease with an interleukin-1 α gene polymorphism. Ann Neurol. 2000;47:361–365
  7. Hedley R, Hallmayer J, Groth DM, Brooks WS, Gandy SE, Martins RN. Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann Neurol. 2002;51:795–797
  8. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin-1 (IL-1)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol. 2000;47:571–574
  9. Ki CS, Na DL, Kim DK, Kim HJ, Kim JW. Lack of association of the gene interleukin-1 alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann Neurol. 2001;49:817–818
  10. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol. 1998;3:327–338
  11. McDowell TL, Symons JA, Ploski R, Forte O, Duff GW. A genetic association between juvenile rheumatoid arthritis, and a novel interleukin-1 α polymorphism. Arthritis Rheum. 1995;38:221–228
  12. Minster RL, DeKosky ST, Ganguli M, Belle S, Kamboh MI. Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol. 2000;48:817–819
  13. Möller JC, Depboylu C, Kölsch H, Lohmüller F, Bandmann O, Gocke P, et al. Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease. Neurosci Lett. 2004;359:195–197
  14. Mrak RE, Griffin WST. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging. 2001;22:903–908
  15. Murzin AG, Lesk AM, Chothia C. β-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 β and 1 α and fibroblast growth factors. J Med Biol. 1992;223:531–543
  16. Nicoll JA, Mral RE, Graham DI, Stewart J, Wilcock G, MacGowan S, et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 2000;47:365–368
  17. Nishimura M, Sakamoto T, Kaji R, Kawakami H. Influence of polymorphism in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci Lett. 2004;23:140–143
  18. O'Neill LA, Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol. 1998;63:650–657
  19. Pirskanen M, Hiltunen M, Mannermaa A, Livonen S, Helisalmi S, Lehtovirta M, et al. Interleukin 1 alpha gene polymorphisms as a susceptibility factor in Alzheimer's disease and its influence on the extend of histopathological hallmark lesions of Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:123–127
  20. Rebeck GW. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett. 2000;293:75–77
  21. Rothwell N. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun. 2003;17:152–157
  22. Rothwell NJ, Luheshi GN. Interleukin-1 in the brain: biology, pathology, and therapeutic target. Trends Neurosci. 2000;23:618–625
  23. Schulte T, Schöls L, Müller T, Woitalla D, Berger K, Krüger R. Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci Lett. 2002;326:70–72
  24. Sheng JG, Boop FA, Mrak RE, Griffin WST. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α immunoreactivity. J Neurochem. 1994;63:1872–1879
  25. Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992;13:654–657
  26. Teasdale GM, Nicoll JAR, Murray G, Fiddes M. Association of apolipoprotein E with outcome after head injury. Lancet. 1997;350:1069–1071
  27. Touzani O, Boutin H, Chuquet J, Rothwell NJ. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol. 1999;100:203–215
  28. Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, et al. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci. 2002;22:38–43
  29. Tsai SJ, Liu HC, Liu TY, Wang KY, Hong CJ. Lack of association between the interleukin-1 alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population. Neurosci Lette. 2003;343:93–96
  30. Uzan M, Tanriverdi T, Baykara O, Kafadar A, Sanus GZ, Ozkara C, et al. ssociation between interleukin-1 beta (IL-1β) gene polymorphism and outcome after head injury: an early report. Acta Neurochir (Wien). 2005;147:715–720

PII: S0090-3019(05)00400-3

doi: 10.1016/j.surneu.2005.05.024

Surgical Neurology
Volume 65, Issue 1 , Pages 7-10 , January 2006

Article Tools